News

Public · Published

Chip Maker Marvell Agrees to Buy Lumentum in $80 Billion Deal— WSJ

Marvell agreed to buy Lumentum in an all-stock deal worth roughly $80 billion. Lumentum stockholders will receive 4.5 Marvell shares for each Lumentum share they own. The deal would join Marvell's custom AI chips and data-center connectivity products with Lumentum's lasers and optical hardware.

Published:

Updated:

What happened

Marvell agreed to buy Lumentum in an all-stock deal worth roughly $80 billion. Lumentum stockholders will receive 4.5 Marvell shares for each Lumentum share they own. The deal would join Marvell’s custom AI chips and data-center connectivity products with Lumentum’s lasers and optical hardware.

Confirmed

Global impact / market context

The combination would give Marvell a broader range of products for moving data inside data centers, including light-based links between chips and servers. If customers adopt these products, the combined company could gain sales from AI infrastructure demand, while issuing shares to fund the purchase would dilute existing shareholders’ ownership.

Analyst inference

Marvell’s data-center segment now generates the majority of its revenue and is its leading growth engine, while Lumentum supplies optical equipment used in data-center servers. The deal therefore ties two businesses to data-center expansion, but the article gives no expected savings, revenue targets, or completion date.

Confirmed

What to watch

  1. Watch for details on shareholder and regulatory approvals and the expected closing date; the supplied article does not state whether the deal has cleared either step. Analyst inference
  2. Check whether the companies disclose how they will combine their chip and optical products, and whether customers can use them together without major redesigns or added costs. Analyst inference
  3. Track any updated exchange terms or financing details, since Lumentum holders are to receive 4.5 Marvell shares per share and the announced deal is all-stock. Confirmed

Evidence

  • Original source link unavailable